Biopsy Market: Global Industry Analysis and Forecast (2024-2030)

Biopsy Market size is expected to grow from US$ 32.38 Bn in 2023 to US$ 67.83 Bn by 2030. The Global Biopsy Market is expected to grow at a CAGR of 11.14% through the forecast period (2024 to 2030).

Biopsy Market Overview

In molecular medicine, biopsies have made major improvements, particularly in cancer. Because of technological developments in the equipment used for biopsies, the molecular characterization of malignancies has improved. They've been widely used to diagnose cancer, figure out the shape of the tumour, and figure out the disease stage. The evolution of the cancer biopsy market hinges on the development of molecular testing. In clinical investigations, biopsies are used to assess pharmaceutical response rates, especially in patients undergoing epidermal growth factor receptor (EGFR) therapy. Biopsy MarketTo know about the Research Methodology :- Request Free Sample Report Biopsy Market Report Scope and Research Methodology The objective of the Biopsy market report is to present a comprehensive analysis of the market to the stakeholders in the Biopsy industry. The past and current status of the industry with the forecasted Biopsy market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of Biopsy key competitors that include market leaders, followers, and new entrants. PORTER, PESTLE analysis with the potential impact of micro-economic factors of the Biopsy market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the Biopsy industry to the decision-makers. The report also help in understanding the Global Biopsy Market dynamic, structure by analyzing the market segments and project the Global size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence make the Global Biopsy Market report investor’s guide.

Biopsy Market Dynamics

Increased Use of Liquid Biopsies driving the Biopsy Market Growth: Liquid biopsie involve the analysis of biological fluids such as blood, urine or cerebrospinal fluid, offer a non-invasive and dynamic approach to detecting and monitoring various diseases, especially cancer. Liquid biopsies majorly provides a non-invasive alternative to traditional tissue biopsies. Compared to surgical procedures, the biological fluids collection, such as blood, is less burdensome for patients. The increasing focus on patient comfort and reducing invasiveness is driving the global market appeal of biopsy procedures, which is driving patient compliance and facilitating more frequent monitoring. Lung cancer is a leading cause of cancer-related deaths across the world, which is driving the development and adoption of liquid biopsy techniques for more effective and less invasive diagnostic and monitoring methods. Thus, resulting to the growth of lung cancer liquid biopsy market, which is also contributing to the global Biopsy Market growth. Integration of Artificial Intelligence (AI) in Pathology Creating Opportunity for the Biopsy Market Growth: The integration of artificial intelligence (AI) in pathology is majorly revolutionizing the global market. AI-driven image analysis and pathology platforms assist pathologists in interpreting the results of biopsy more efficiently and accurately. This technological integration is streamlining diagnostic processes, reducing turnaround times, and contributing to the growth and efficiency of the market. AI is highly facilitating the digitization of pathology slides, which is enabling remote consultations and telepathology services. Pathologists share digital images for expert opinions, fostering collaboration across geographical distances. This capability majorly enhances accessibility to specialized expertise, especially in areas with limited access to pathology services, driving the global biopsy market growth. Costs Associated with Biopsy Procedures Restraining the Biopsy Market Growth: The costs associated with biopsy procedures, including preoperative assessments, facility fees, and postoperative care, is a key restraint for the market growth. The financial burden on patients and healthcare systems limits the accessibility and adoption of certain biopsy methods, especially in regions with constrained healthcare budgets or for individuals without adequate insurance coverage. These high costs associated with the biopsy procedures are unaffordable low income groups and some middle income groups. Financial considerations contribute to unequal access to biopsy services, which creates disparities in healthcare. Individuals with limited financial means or those without comprehensive insurance coverage face challenges in accessing biopsy procedures, which leads to delayed or missed diagnoses. Addressing these disparities is very important for achieving equitable healthcare and fostering market growth.

Biopsy Market Regional Insights

North America dominates the Global Biopsy market during the forecast period 2024-2030. North America held the largest market share of 40% in 2023 and is expected to continue its dominance in the forecast period 2030. During the forecast period, the region is expected to maintain its lead, with the United States contributing significantly to regional revenue. The increased adoption of technologically improved equipment for early sickness diagnosis is one of the key factors driving the market. In this region, distributors and manufacturers are also looking to create new kits that are well-suited for rapid diagnostic applications. The increasing demand for less invasive procedures, an increase in the number of cancer patients, and government programmes for early cancer diagnosis are the crucial factors driving market growth in the North American region. In addition, there is a huge increase in demand for minimally invasive biopsy techniques on the market. During the forecast period, numerous types of technologies and products, including as biopsy guiding systems, needle-based biopsy guns, and vacuum-assisted devices, are expected to increase rapidly. As a result of the factors mentioned above, the market is estimated to increase significantly over the forecast period. Asia Pacific is expected to grow rapidly at a CAGR of 29.1% during the forecast period 2024-2030. Its popularity has increased in lockstep with public knowledge of cancer's morbidity. The high prevalence of breast cancer has fuelled demand for biopsies, and the region's global cancer biopsy market growth potential is being boosted by favourable reimbursement and payer networks. One of the major factors driving the market in the Asia Pacific region is the increased prevalence of cancer, as well as growing measures to raise awareness about cancer screening programmes. Furthermore, the rising risks of infection as a result of inappropriate management of invasive biopsy wounds have prompted the implementation of more stringent healthcare guidelines, which has boosted market growth. Skin biopsy, a diagnostic procedure involving the removal of a small sample of skin tissue for examination, is witnessing increased demand in the region. The growth of skin biopsy market is also majorly contributing to the growth of regional market.

Biopsy Market Segment Analysis

Based on the Product, the market is segmented into Instruments, Kits and Consumables, and Services. The Kits and Consumables segment held the largest Biopsy market share of 60.0% in 2023 and is expected to continue its dominance during the forecast period. This is due to the kits and consumables are crucial at different phases of biopsies. Furthermore, large investments by major players in the Biopsy industry have contributed significantly to the segment's growth. The segment's rise may also be due to an increase in the number of patients around the world who require efficient, precise, and quick tools and kits. In terms of devices, kits, and consumables, cancer biopsy has seen a number of advancements. The creation of effective products connected with biopsies is critical as liquid biopsy becomes a multimodal tool of diagnosis in the field of clinical cancer. Despite the fact that existing instruments are widely utilized, they have a number of flaws. The introduction of new technologies, on the other hand, is expected to dramatically enhance the need for instruments in the forecast period. Based on the Application, the market is segmented into Breast Cancer, Colorectal Cancer, Cervical Cancers, Lung Cancers, Prostate Cancers, Skin Cancers, Blood Cancers, Kidney Cancers, Liver Cancers, Pancreatic Cancers, Ovarian Cancers, and Others. The Breast Cancer segment is expected to grow rapidly at a high CAGR during the forecast period 2024-2030. Breast cancer is the most frequent type of cancer. According to breast cancer statistics in the United States, one out of every eight women develops invasive breast cancer. In the United States, an approximate 276,480 new cases of invasive breast cancer would be diagnosed in women in 2021, with more than 40,000 new cases of non-invasive breast cancer. These is resulting in a growth of the breast biopsy devices market and breast cancer liquid biopsy market in the US. Microscopic investigation of breast tissue is required for obtaining a definitive diagnosis, as well as detecting the stage and characterization of type, in the growing number of individuals suspected of having breast cancer. The demand for a needle biopsy or surgical biopsy to acquire tissue for microscopic inspection has risen as a result, leading to segment growth. This increasing demand is also contributing to the growth of surgical biopsy and needle biopsy market.

Biopsy Market Scope: Inquire before buying

Biopsy Market
Report Coverage Details
Base Year: 2023 Forecast Period: 2024-2030
Historical Data: 2018 to 2023 Market Size in 2023: US $ 32.38 Bn.
Forecast Period 2024 to 2030 CAGR: 11.14% Market Size in 2030: US $ 67.83 Bn.
Segments Covered: by Product Instruments Kits and Consumables Services
by Type Tissue Biopsies Liquid Biopsies Others
by Application Breast Cancer Colorectal Cancer Cervical Cancers Lung Cancers Prostate Cancers Skin Cancers Blood Cancers Kidney Cancers Liver Cancers Pancreatic Cancers Ovarian Cancers Others

Biopsy Market, by Region

North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (razil, Argentina Rest of South America)

Biopsy Key Players

North America 1. Illumina, Inc.(U.S) 2. Quest Diagnostics (U.S) 3. Abbott Laboratories (U.S) 4. GenMark Diagnostics(U.S) 5. Bio-Rad Laboratories (U.S) 6. Agilent Technologies (U.S) 7. Biomarker Technologies (U.S) 8. Coherent, Inc. (U.S) 9. Cardinal Health (U.S) 10. BD (Becton, Dickinson and Company) (U.S) 11. Myriad Genetics (U.S) 12. Hologic, Inc. (U.S) 13. Biocept, Inc. (U.S) 14. Thermo Fisher Scientific, Inc. (U.S) 15. Danaher (U.S) 16. Guardant Health (U.S) 17. Exact Sciences Corporation (U.S) 18. Freenome Holdings, Inc. (U.S) 19. Biodesix (Integrated Diagnostics) (U.S) 20. HelioHealth (Laboratory for Advanced Medicine) (U.S) 21. Genesystems, Inc. (Genesys Biolabs)(U.S) 22. GRAIL, Inc. (U.S) Europe 1. ANGLE Plc (U.K) 2. Oncimmune (U.K) 3. Epigenomics AG (Germany) 4. Qiagen N.V. (Netherlands) 5. F. Hoffmann-La Roche Ltd. (Switzerland) Asia Pacific 1. Sysmex Corporation (Japan) 2. Olympus(Japan) 3. Lucence Diagnostics Pte. Ltd. (Singapore) Frequently Asked Questions: 1] What segments are covered in Global Biopsy Market report? Ans. The segments covered in Global Biopsy Market report are based on Product, Type, and Application. 2] Which region is expected to hold the largest Biopsy Market share in 2023? Ans. North America is expected to hold the largest Biopsy Market share in 2023. 3] Who are the top players in the Global Biopsy Market? Ans. Qiagen N.V., Illumina, Inc., ANGLE Plc, BD (Becton, Dickinson and Company), and Myriad Genetics are the top players in the Global Biopsy Market. 4] Which segment is expected to hold the largest Biopsy market share by 2030? Ans. Kits and Consumables product segment is expected to hold the largest Biopsy market share by 2030. 5] What is the expected Global Biopsy market size by 2030? Ans. The expected Global Biopsy market size is US$ 67.83 Bn by 2030. 6] What was the Global Biopsy market size in 2023? Ans. The Global Biopsy market size was worth US$ 32.38 Bn in 2023.
1. Biopsy Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Biopsy Market: Dynamics 2.1. Biopsy Market Trends by Region 2.1.1. Global Biopsy Market Trends 2.1.2. North America Biopsy Market Trends 2.1.3. Europe Biopsy Market Trends 2.1.4. Asia Pacific Biopsy Market Trends 2.1.5. Middle East and Africa Biopsy Market Trends 2.1.6. South America Biopsy Market Trends 2.2. Biopsy Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Biopsy Market Drivers 2.2.1.2. North America Biopsy Market Restraints 2.2.1.3. North America Biopsy Market Opportunities 2.2.1.4. North America Biopsy Market Challenges 2.2.2. Europe 2.2.2.1. Europe Biopsy Market Drivers 2.2.2.2. Europe Biopsy Market Restraints 2.2.2.3. Europe Biopsy Market Opportunities 2.2.2.4. Europe Biopsy Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Biopsy Market Drivers 2.2.3.2. Asia Pacific Biopsy Market Restraints 2.2.3.3. Asia Pacific Biopsy Market Opportunities 2.2.3.4. Asia Pacific Biopsy Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Biopsy Market Drivers 2.2.4.2. Middle East and Africa Biopsy Market Restraints 2.2.4.3. Middle East and Africa Biopsy Market Opportunities 2.2.4.4. Middle East and Africa Biopsy Market Challenges 2.2.5. South America 2.2.5.1. South America Biopsy Market Drivers 2.2.5.2. South America Biopsy Market Restraints 2.2.5.3. South America Biopsy Market Opportunities 2.2.5.4. South America Biopsy Market Challenges 2.3. PORTER’s Five Types Analysis 2.4. PESTLE Analysis 2.5. Value Chain Analysis 2.6. Regulatory Landscape by Region 2.6.1. Global 2.6.2. North America 2.6.3. Europe 2.6.4. Asia Pacific 2.6.5. Middle East and Africa 2.6.6. South America 2.7. Key Opinion Leader Analysis For the Biopsy Industry 2.8. Analysis of Government Schemes and Initiatives For the Biopsy Industry 2.9. The Global Pandemic Impact on the Biopsy Market 3. Biopsy Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value) (2023-2030) 3.1. Biopsy Market Size and Forecast, by Product Type (2023-2030) 3.1.1. Instruments 3.1.2. Kits and Consumables 3.1.3. Services 3.2. Biopsy Market Size and Forecast, by Type (2023-2030) 3.2.1. Tissue Biopsies 3.2.2. Liquid Biopsies 3.2.3. Others 3.3. Biopsy Market Size and Forecast, by Application (2023-2030) 3.3.1. Breast Cancer 3.3.2. Colorectal Cancer 3.3.3. Cervical Cancers 3.3.4. Lung Cancers 3.3.5. Prostate Cancers 3.3.6. Skin Cancers 3.3.7. Blood Cancers 3.3.8. Kidney Cancers 3.3.9. Liver Cancers 3.3.10. Pancreatic Cancers 3.3.11. Ovarian Cancers 3.3.12. Others 3.4. Biopsy Market Size and Forecast, by Region (2023-2030) 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Middle East and Africa 3.4.5. South America 4. North America Biopsy Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) (2023-2030) 4.1. North America Biopsy Market Size and Forecast, by Product Type (2023-2030) 4.1.1. Instruments 4.1.2. Kits and Consumables 4.1.3. Services 4.2. North America Biopsy Market Size and Forecast, by Type (2023-2030) 4.2.1. Tissue Biopsies 4.2.2. Liquid Biopsies 4.2.3. Others 4.3. North America Biopsy Market Size and Forecast, by Application (2023-2030) 4.3.1. Breast Cancer 4.3.2. Colorectal Cancer 4.3.3. Cervical Cancers 4.3.4. Lung Cancers 4.3.5. Prostate Cancers 4.3.6. Skin Cancers 4.3.7. Blood Cancers 4.3.8. Kidney Cancers 4.3.9. Liver Cancers 4.3.10. Pancreatic Cancers 4.3.11. Ovarian Cancers 4.3.12. Others 4.4. North America Biopsy Market Size and Forecast, by Country (2023-2030) 4.4.1. United States 4.4.1.1. United States Biopsy Market Size and Forecast, by Product Type (2023-2030) 4.4.1.1.1. Instruments 4.4.1.1.2. Kits and Consumables 4.4.1.1.3. Services 4.4.1.2. United States Biopsy Market Size and Forecast, by Type (2023-2030) 4.4.1.2.1. Tissue Biopsies 4.4.1.2.2. Liquid Biopsies 4.4.1.2.3. Others 4.4.1.3. United States Biopsy Market Size and Forecast, by Application (2023-2030) 4.4.1.3.1. Breast Cancer 4.4.1.3.2. Colorectal Cancer 4.4.1.3.3. Cervical Cancers 4.4.1.3.4. Lung Cancers 4.4.1.3.5. Prostate Cancers 4.4.1.3.6. Skin Cancers 4.4.1.3.7. Blood Cancers 4.4.1.3.8. Kidney Cancers 4.4.1.3.9. Liver Cancers 4.4.1.3.10. Pancreatic Cancers 4.4.1.3.11. Ovarian Cancers 4.4.1.3.12. Others 4.4.2. Canada 4.4.2.1. Canada Biopsy Market Size and Forecast, by Product Type (2023-2030) 4.4.2.1.1. Instruments 4.4.2.1.2. Kits and Consumables 4.4.2.1.3. Services 4.4.2.2. Canada Biopsy Market Size and Forecast, by Type (2023-2030) 4.4.2.2.1. Tissue Biopsies 4.4.2.2.2. Liquid Biopsies 4.4.2.2.3. Others 4.4.2.3. Canada Biopsy Market Size and Forecast, by Application (2023-2030) 4.4.2.3.1. Breast Cancer 4.4.2.3.2. Colorectal Cancer 4.4.2.3.3. Cervical Cancers 4.4.2.3.4. Lung Cancers 4.4.2.3.5. Prostate Cancers 4.4.2.3.6. Skin Cancers 4.4.2.3.7. Blood Cancers 4.4.2.3.8. Kidney Cancers 4.4.2.3.9. Liver Cancers 4.4.2.3.10. Pancreatic Cancers 4.4.2.3.11. Ovarian Cancers 4.4.2.3.12. Others 4.4.3. Mexico 4.4.3.1. Mexico Biopsy Market Size and Forecast, by Product Type (2023-2030) 4.4.3.1.1. Instruments 4.4.3.1.2. Kits and Consumables 4.4.3.1.3. Services 4.4.3.2. Mexico Biopsy Market Size and Forecast, by Type (2023-2030) 4.4.3.2.1. Tissue Biopsies 4.4.3.2.2. Liquid Biopsies 4.4.3.2.3. Others 4.4.3.3. Mexico Biopsy Market Size and Forecast, by Application (2023-2030) 4.4.3.3.1. Breast Cancer 4.4.3.3.2. Colorectal Cancer 4.4.3.3.3. Cervical Cancers 4.4.3.3.4. Lung Cancers 4.4.3.3.5. Prostate Cancers 4.4.3.3.6. Skin Cancers 4.4.3.3.7. Blood Cancers 4.4.3.3.8. Kidney Cancers 4.4.3.3.9. Liver Cancers 4.4.3.3.10. Pancreatic Cancers 4.4.3.3.11. Ovarian Cancers 4.4.3.3.12. Others 5. Europe Biopsy Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) (2023-2030) 5.1. Europe Biopsy Market Size and Forecast, by Product Type (2023-2030) 5.2. Europe Biopsy Market Size and Forecast, by Type (2023-2030) 5.3. Europe Biopsy Market Size and Forecast, by Application (2023-2030) 5.4. Europe Biopsy Market Size and Forecast, by Country (2023-2030) 5.4.1. United Kingdom 5.4.1.1. United Kingdom Biopsy Market Size and Forecast, by Product Type (2023-2030) 5.4.1.2. United Kingdom Biopsy Market Size and Forecast, by Type (2023-2030) 5.4.1.3. United Kingdom Biopsy Market Size and Forecast, by Application (2023-2030) 5.4.2. France 5.4.2.1. France Biopsy Market Size and Forecast, by Product Type (2023-2030) 5.4.2.2. France Biopsy Market Size and Forecast, by Type (2023-2030) 5.4.2.3. France Biopsy Market Size and Forecast, by Application (2023-2030) 5.4.3. Germany 5.4.3.1. Germany Biopsy Market Size and Forecast, by Product Type (2023-2030) 5.4.3.2. Germany Biopsy Market Size and Forecast, by Type (2023-2030) 5.4.3.3. Germany Biopsy Market Size and Forecast, by Application (2023-2030) 5.4.4. Italy 5.4.4.1. Italy Biopsy Market Size and Forecast, by Product Type (2023-2030) 5.4.4.2. Italy Biopsy Market Size and Forecast, by Type (2023-2030) 5.4.4.3. Italy Biopsy Market Size and Forecast, by Application (2023-2030) 5.4.5. Spain 5.4.5.1. Spain Biopsy Market Size and Forecast, by Product Type (2023-2030) 5.4.5.2. Spain Biopsy Market Size and Forecast, by Type (2023-2030) 5.4.5.3. Spain Biopsy Market Size and Forecast, by Application (2023-2030) 5.4.6. Sweden 5.4.6.1. Sweden Biopsy Market Size and Forecast, by Product Type (2023-2030) 5.4.6.2. Sweden Biopsy Market Size and Forecast, by Type (2023-2030) 5.4.6.3. Sweden Biopsy Market Size and Forecast, by Application (2023-2030) 5.4.7. Austria 5.4.7.1. Austria Biopsy Market Size and Forecast, by Product Type (2023-2030) 5.4.7.2. Austria Biopsy Market Size and Forecast, by Type (2023-2030) 5.4.7.3. Austria Biopsy Market Size and Forecast, by Application (2023-2030) 5.4.8. Rest of Europe 5.4.8.1. Rest of Europe Biopsy Market Size and Forecast, by Product Type (2023-2030) 5.4.8.2. Rest of Europe Biopsy Market Size and Forecast, by Type (2023-2030) 5.4.8.3. Rest of Europe Biopsy Market Size and Forecast, by Application (2023-2030) 6. Asia Pacific Biopsy Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) (2023-2030) 6.1. Asia Pacific Biopsy Market Size and Forecast, by Product Type (2023-2030) 6.2. Asia Pacific Biopsy Market Size and Forecast, by Type (2023-2030) 6.3. Asia Pacific Biopsy Market Size and Forecast, by Application (2023-2030) 6.4. Asia Pacific Biopsy Market Size and Forecast, by Country (2023-2030) 6.4.1. China 6.4.1.1. China Biopsy Market Size and Forecast, by Product Type (2023-2030) 6.4.1.2. China Biopsy Market Size and Forecast, by Type (2023-2030) 6.4.1.3. China Biopsy Market Size and Forecast, by Application (2023-2030) 6.4.2. S Korea 6.4.2.1. S Korea Biopsy Market Size and Forecast, by Product Type (2023-2030) 6.4.2.2. S Korea Biopsy Market Size and Forecast, by Type (2023-2030) 6.4.2.3. S Korea Biopsy Market Size and Forecast, by Application (2023-2030) 6.4.3. Japan 6.4.3.1. Japan Biopsy Market Size and Forecast, by Product Type (2023-2030) 6.4.3.2. Japan Biopsy Market Size and Forecast, by Type (2023-2030) 6.4.3.3. Japan Biopsy Market Size and Forecast, by Application (2023-2030) 6.4.4. India 6.4.4.1. India Biopsy Market Size and Forecast, by Product Type (2023-2030) 6.4.4.2. India Biopsy Market Size and Forecast, by Type (2023-2030) 6.4.4.3. India Biopsy Market Size and Forecast, by Application (2023-2030) 6.4.5. Australia 6.4.5.1. Australia Biopsy Market Size and Forecast, by Product Type (2023-2030) 6.4.5.2. Australia Biopsy Market Size and Forecast, by Type (2023-2030) 6.4.5.3. Australia Biopsy Market Size and Forecast, by Application (2023-2030) 6.4.6. Indonesia 6.4.6.1. Indonesia Biopsy Market Size and Forecast, by Product Type (2023-2030) 6.4.6.2. Indonesia Biopsy Market Size and Forecast, by Type (2023-2030) 6.4.6.3. Indonesia Biopsy Market Size and Forecast, by Application (2023-2030) 6.4.7. Malaysia 6.4.7.1. Malaysia Biopsy Market Size and Forecast, by Product Type (2023-2030) 6.4.7.2. Malaysia Biopsy Market Size and Forecast, by Type (2023-2030) 6.4.7.3. Malaysia Biopsy Market Size and Forecast, by Application (2023-2030) 6.4.8. Vietnam 6.4.8.1. Vietnam Biopsy Market Size and Forecast, by Product Type (2023-2030) 6.4.8.2. Vietnam Biopsy Market Size and Forecast, by Type (2023-2030) 6.4.8.3. Vietnam Biopsy Market Size and Forecast, by Application (2023-2030) 6.4.9. Taiwan 6.4.9.1. Taiwan Biopsy Market Size and Forecast, by Product Type (2023-2030) 6.4.9.2. Taiwan Biopsy Market Size and Forecast, by Type (2023-2030) 6.4.9.3. Taiwan Biopsy Market Size and Forecast, by Application (2023-2030) 6.4.10. Rest of Asia Pacific 6.4.10.1. Rest of Asia Pacific Biopsy Market Size and Forecast, by Product Type (2023-2030) 6.4.10.2. Rest of Asia Pacific Biopsy Market Size and Forecast, by Type (2023-2030) 6.4.10.3. Rest of Asia Pacific Biopsy Market Size and Forecast, by Application (2023-2030) 7. Middle East and Africa Biopsy Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) (2023-2030) 7.1. Middle East and Africa Biopsy Market Size and Forecast, by Product Type (2023-2030) 7.2. Middle East and Africa Biopsy Market Size and Forecast, by Type (2023-2030) 7.3. Middle East and Africa Biopsy Market Size and Forecast, by Application (2023-2030) 7.4. Middle East and Africa Biopsy Market Size and Forecast, by Country (2023-2030) 7.4.1. South Africa 7.4.1.1. South Africa Biopsy Market Size and Forecast, by Product Type (2023-2030) 7.4.1.2. South Africa Biopsy Market Size and Forecast, by Type (2023-2030) 7.4.1.3. South Africa Biopsy Market Size and Forecast, by Application (2023-2030) 7.4.2. GCC 7.4.2.1. GCC Biopsy Market Size and Forecast, by Product Type (2023-2030) 7.4.2.2. GCC Biopsy Market Size and Forecast, by Type (2023-2030) 7.4.2.3. GCC Biopsy Market Size and Forecast, by Application (2023-2030) 7.4.3. Nigeria 7.4.3.1. Nigeria Biopsy Market Size and Forecast, by Product Type (2023-2030) 7.4.3.2. Nigeria Biopsy Market Size and Forecast, by Type (2023-2030) 7.4.3.3. Nigeria Biopsy Market Size and Forecast, by Application (2023-2030) 7.4.4. Rest of ME&A 7.4.4.1. Rest of ME&A Biopsy Market Size and Forecast, by Product Type (2023-2030) 7.4.4.2. Rest of ME&A Biopsy Market Size and Forecast, by Type (2023-2030) 7.4.4.3. Rest of ME&A Biopsy Market Size and Forecast, by Application (2023-2030) 8. South America Biopsy Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) (2023-2030) 8.1. South America Biopsy Market Size and Forecast, by Product Type (2023-2030) 8.2. South America Biopsy Market Size and Forecast, by Type (2023-2030) 8.3. South America Biopsy Market Size and Forecast, by Application (2023-2030) 8.4. South America Biopsy Market Size and Forecast, by Country (2023-2030) 8.4.1. Brazil 8.4.1.1. Brazil Biopsy Market Size and Forecast, by Product Type (2023-2030) 8.4.1.2. Brazil Biopsy Market Size and Forecast, by Type (2023-2030) 8.4.1.3. Brazil Biopsy Market Size and Forecast, by Application (2023-2030) 8.4.2. Argentina 8.4.2.1. Argentina Biopsy Market Size and Forecast, by Product Type (2023-2030) 8.4.2.2. Argentina Biopsy Market Size and Forecast, by Type (2023-2030) 8.4.2.3. Argentina Biopsy Market Size and Forecast, by Application (2023-2030) 8.4.3. Rest Of South America 8.4.3.1. Rest Of South America Biopsy Market Size and Forecast, by Product Type (2023-2030) 8.4.3.2. Rest Of South America Biopsy Market Size and Forecast, by Type (2023-2030) 8.4.3.3. Rest Of South America Biopsy Market Size and Forecast, by Application (2023-2030) 9. Global Biopsy Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Service Segment 9.3.3. End-user Segment 9.3.4. Revenue (2023) 9.3.5. Company Locations 9.4. Leading Biopsy Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Illumina, Inc. 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Quest Diagnostics 10.3. Abbott Laboratories 10.4. GenMark Diagnostics 10.5. Bio-Rad Laboratories 10.6. Agilent Technologies 10.7. Biomarker Technologies 10.8. Coherent, Inc. 10.9. Cardinal Health 10.10. BD (Becton, Dickinson and Company) 10.11. Myriad Genetics 10.12. Hologic, Inc. 10.13. Biocept, Inc. 10.14. Thermo Fisher Scientific, Inc. 10.15. Danaher 10.16. Guardant Health 10.17. Exact Sciences Corporation 10.18. Freenome Holdings, Inc. 10.19. Biodesix (Integrated Diagnostics) 10.20. HelioHealth (Laboratory for Advanced Medicine) 10.21. Genesystems, Inc. (Genesys Biolabs) 10.22. GRAIL, Inc. 10.23. ANGLE Plc 10.24. Oncimmune 10.25. Epigenomics AG 10.26. Qiagen N.V. 10.27. F. Hoffmann-La Roche Ltd. 10.28. Sysmex Corporation 10.29. Olympus 10.30. Lucence Diagnostics Pte. Ltd. 11. Key Findings 12. Industry Recommendations 13. Biopsy Market: Research Methodology 14. Terms and Glossary
  • INQUIRE BEFORE BUYING